-
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)
14 Dec 2020 13:47 GMT
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHPC— …
-
AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients
14 Oct 2020 20:11 GMT
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of …
-
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Eaton Vance Corp., MobileIron, Inc., and Seacoast Commerce Banc Holdings
30 Oct 2020 19:29 GMT
… . 30, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Lifshitz Law … at info@jlclasslaw.com. ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P …
-
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)
06 Oct 2020 01:05 GMT
The product remains on the market
AMAG has 15 days to respond to the FDA
AMAG continues to expect its recently announced tender offer and merger to close in November 2020
WALTHAM, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: …
-
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
01 Oct 2020 14:45 GMT
Addition of AMAG’s category leading treatments positions Covis to become a global market leader of therapeutic solutions for life-threatening conditions and chronic illnesses
Covis will commence a tender offer to acquire all the outstanding shares of AMAG …
-
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., MobileIron, Inc., Monaker Group, Inc., and Seacoast Commerce Banc Holdings
07 Oct 2020 15:25 GMT
… . 07, 2020 (GLOBE NEWSWIRE) --
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Lifshitz Law … at info@jlclasslaw.com. ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P …
-
AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference
09 Sep 2020 12:00 GMT
WALTHAM, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Scott Myers, Chief Executive Officer, and Brian Piekos, Chief Financial Officer, will participate in a fireside chat at the H.C. Wainwright …
-
AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update
06 Aug 2020 11:00 GMT
Financial guidance reissued to include EBITDA-positive projection for second-half 2020
Strategic shift and momentum build through recent business development activities Brian Piekos promoted to Chief Financial Officer Conference call scheduled for 8:00 a.m …
-
AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020
28 Jul 2020 12:00 GMT
WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will …
-
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
27 Jul 2020 11:30 GMT
Vyleesi® returned to Palatin Technologies
Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin …
About
© 1995-2026